Skip to main content
. 2021 Nov 23;145(5):1668–1683. doi: 10.1093/brain/awab327

Figure 6.

Figure 6

Comparative effectiveness assessment of ASM and treatment responses. (A) Selection of ASM prescriptions extracted from the EMR, across ages 0–5 years in a subset of individuals with STXBP1. (B) Extension of A, showing the distribution of individuals on ASM and ketogenic diet across ages 0–20 years. (C) Relative effectiveness of ASM in reducing seizure frequency. (D) Relative effectiveness of ASM in reducing seizure frequency or maintaining seizure freedom. (E) Relative effectiveness of ASM in maintaining seizure freedom. Odds ratios were calculated based on changes in seizure frequency to ASM use across monthly time intervals.